Fragment, Modified GRF, Ipamorelin 12mg

Research has shown that achieving maximum natural growth hormone (GH) release by the anterior pituitary can be accomplished, in general, by combining a growth hormone releasing hormone (GHRH) analogue with a growth hormone secretagogue receptor (GHSR) agonist. There are multiple combinations that can accomplish this goal, including combining modified GRF with ipamorelin. Of course, sometimes the goal might be to achieve more specific effects in addition to maximum GH release. In other words, by fine tuning the types of GHRH agonist and GHSR agonist used, it could be possible to create more targeted outcomes.